M&A Deal Summary |
|
|---|---|
| Date | 2012-07-16 |
| Target | Morphormics |
| Sector | Healthcare Services |
| Buyer(s) | Accuray |
| Deal Type | Add-on Acquisition |
| Deal Value | 6M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Medical Products |
| Employees | 987 |
| Revenue | 447M USD (2024) |
Accuray is a radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. Accuray was founded in 1990 and is based in Madison, Wisconsin.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2012 M&A | 1 of 1 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-03-07 |
TomoTherapy
Sunnyvale, California, United States TomoTherapy, Inc. is a developer, manufacturer and seller of advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. |
Buy | $277M |
